Skull Base 2010; 20(6): 409-414
DOI: 10.1055/s-0030-1253575
ORIGINAL ARTICLE

© Thieme Medical Publishers

Applicability of the Pittsburgh Staging System for Advanced Cutaneous Malignancy of the Temporal Bone

Jacques E. Gaudet1 , Rohan R. Walvekar1 , Moises A. Arriaga1 , Michael D. Dileo1 , Daniel W. Nuss1 , Anna M. Pou1 , Joseph Hagan2 , James Lin1
  • 1Department of Otolaryngology–Head and Neck Surgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana
  • 2Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana
Further Information

Publication History

Publication Date:
10 May 2010 (online)

ABSTRACT

The objectives are to evaluate the applicability of the Pittsburgh staging system (PSS) (designed for primary temporal bone malignancies) to advanced periauricular cutaneous malignancies with temporal bone involvement and to study treatment outcomes and prognostic factors predicting recurrence-free survival. Ten patients with advanced periauricular cutaneous malignancy with temporal bone involvement were identified. Patients with primary temporal bone or parotid gland malignancies were excluded. All patients were clinically T4 at presentation by the American Joint Committee on Cancer (AJCC) staging system. Using Pittsburgh staging, six were T1 (stage I) and four were T4 (stage III). The mean follow-up was 13.6 months (3 to 24 months). Patients with basal cell carcinoma were managed with wide local excision and lateral temporal bone resection (WLE/LTBR) without adjuvant therapy. Two of three (66%) are alive and free of disease; one patient died of other causes. Treatment for squamous cell carcinoma patients involved multimodality therapy. Kaplan–Meier survival curves show a worse prognosis in terms of disease-specific survival for patients with higher-staged PSS tumors. This did not reach statistical significance. The PSS may provide additional prognostic information on advanced cutaneous malignancies of the temporal bone over the more widely used AJCC staging system. However, further prospective multicenter studies with larger sample size are required to validate our findings. Basal cell carcinoma was well controlled with WLE/LTBR alone without adjuvant therapy, whereas squamous cell carcinoma required multimodality therapy: WLE/LTBR and postoperative radiation with or without chemotherapy.

REFERENCES

  • 1 Jemal A, Siegel R, Ward E et al.. Cancer statistics, 2008.  CA Cancer J Clin. 2008;  58(2) 71-96
  • 2 Estrem S A, Renner G J. Special problems associated with cutaneous carcinoma of the ear.  Otolaryngol Clin North Am. 1993;  26(2) 231-245
  • 3 Ahmad I, Das Gupta A R. Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna.  J Laryngol Otol. 2001;  115(2) 85-86
  • 4 Skin Cancer Treatment .National Cancer Institute Website. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/skin/HealthProfessional/page4 Accessed February 8, 2010
  • 5 Dinehart S M, Peterson S. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system.  Dermatol Surg. 2005;  31(11 Pt 1) 1379-1384
  • 6 Niparko J K, Swanson N A, Baker S R, Telian S A, Sullivan M J, Kemink J L. Local control of auricular, periauricular, and external canal cutaneous malignancies with Mohs surgery.  Laryngoscope. 1990;  100(10 Pt 1) 1047-1051
  • 7 Gal T J, Futran N D, Bartels L J, Klotch D W. Auricular carcinoma with temporal bone invasion: outcome analysis.  Otolaryngol Head Neck Surg. 1999;  121(1) 62-65
  • 8 Clark R R, Soutar D S. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis.  J Plast Reconstr Aesthet Surg. 2008;  61(10) 1140-1147
  • 9 Levine H. Cutaneous carcinoma of the head and neck: management of massive and previously uncontrolled lesions.  Laryngoscope. 1983;  93(1) 87-105
  • 10 Shotton J C, Sergeant R J, Tanner N S, Allen J P. Lateral temporal bone resection for extensive pinnal malignancy. Has anything changed in forty years?.  J Laryngol Otol. 1993;  107(8) 697-702
  • 11 Prasad S, Janecka I P. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review.  Otolaryngol Head Neck Surg. 1994;  110(3) 270-280
  • 12 Kinney S E, Wood B G. Malignancies of the external ear canal and temporal bone: surgical techniques and results.  Laryngoscope. 1987;  97(2) 158-164
  • 13 Arriaga M A, Curtin H, Takahashi H, Hirsch B E, Kamerer D B. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings.  Ann Otol Rhinol Laryngol. 1990;  99(9 Pt 1) 714-721
  • 14 Moody S A, Hirsch B E, Myers E N. Squamous cell carcinoma of the external auditory canal: an evaluation of a staging system.  Am J Otol. 2000;  21(4) 582-588

James LinM.D. 

LSU Health Sciences Center, 533 Bolivar Street

Suite 566, New Orleans, LA 70112

Email: jlin@lsuhsc.edu

    >